Author

Michael A. Tartell

Rockefeller UniversityORCID 0000-0002-4518-4187Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Christopher BiancoiD· 2 shared Manivel LodhaiD· 2 shared Paul D. BieniasziD· 2 shared Théodora HatziioannouiD· 2 shared Adrianus C. M. BooniD· 1 shared Alex Stabell· 1 shared Carolina Alisio· 1 shared Daniel PostoniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Christopher BiancoORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic innovation in coronaviruses driven by a viral nuclease

Christopher Bianco, Alex Stabell, Manivel Lodha, Miranda Aldis, Michael A. Tartell, Théodora Hatziioannou, Paul D. Bieniasz

This study shows that the coronavirus nuclease NSP15 drives insertion mutations, which can enhance viral transmissibility, as seen in the SARS-CoV-2 furin cleavage site.

bioRxiv · Aug 19, 2026 · PreprintMicrobiology

Interferon-gamma induced RNF213 targets nascent double membrane vesicles to inhibit coronavirus primary translation

Michael A. Tartell, Randa Tissawak, Lennard Voss, Manivel Lodha, Christopher Bianco, Masashi Iwamoto, Daniel Poston, Théodora Hatziioannou, Yiska Weisblum, Paul D. Bieniasz

This study identifies RNF213 as an IFN-gamma-induced antiviral protein that inhibits coronavirus translation by targeting nascent double membrane vesicles.

bioRxiv · Jun 4, 2026 · PreprintMicrobiology

Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1

Victoria S. Banas, Kuljeet Seehra, Matthew W. Mahoney, Carolina Alisio, Yevhenii A. Kyriukha, Elizabeth A. Weiland, Michelle Fath, Zhenfu Han, Traci L. Bricker, Michael A. Tartell, Sean P. J. Whelan, Adrianus C. M. Boon, James W. Janetka

The paper develops and tests new inhibitors of TMPRSS2 to block replication of SARS-CoV-2 and H1N1 influenza virus.

European Journal of Medicinal Chemistry · Nov 21, 2025Peer-reviewedMicrobiology